###begin article-title 0
Gremlin Enhances the Determined Path to Cardiomyogenesis
###end article-title 0
###begin p 1
Conceived and designed the experiments: AU DK. Performed the experiments: DK HM RI KM. Analyzed the data: AU AN DK YT RI MT MW. Contributed reagents/materials/analysis tools: IK AN IS HS. Wrote the paper: AU DK.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
The critical event in heart formation is commitment of mesodermal cells to a cardiomyogenic fate, and cardiac fate determination is regulated by a series of cytokines. Bone morphogenetic proteins (BMPs) and fibroblast growth factors have been shown to be involved in this process, however additional factors needs to be identified for the fate determination, especially at the early stage of cardiomyogenic development.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 104 111 104 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gremlin</italic>
###xml 113 118 113 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grem1</italic>
###xml 156 164 156 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 50 55 <span type="species:ncbi:9606">human</span>
Global gene expression analysis using a series of human cells with a cardiomyogenic potential suggested Gremlin (Grem1) is a candidate gene responsible for in vitro cardiomyogenic differentiation. Grem1, a known BMP antagonist, enhanced DMSO-induced cardiomyogenesis of P19CL6 embryonal carcinoma cells (CL6 cells) 10-35 fold in an area of beating differentiated cardiomyocytes. The Grem1 action was most effective at the early differentiation stage when CL6 cells were destined to cardiomyogenesis, and was mediated through inhibition of BMP2. Furthermore, BMP2 inhibited Wnt/beta-catenin signaling that promoted CL6 cardiomyogenesis.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 282 287 <span type="species:ncbi:9606">human</span>
Grem1 enhances the determined path to cardiomyogenesis in a stage-specific manner, and inhibition of the BMP signaling pathway is involved in initial determination of Grem1-promoted cardiomyogenesis. Our results shed new light on renewal of the cardiovascular system using Grem1 in human.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 324 327 324 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002407-Andree1">[1]</xref>
###xml 328 331 328 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002407-Angello1">[3]</xref>
###xml 370 373 370 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002407-Alsan1">[4]</xref>
###xml 374 377 374 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002407-Whitehead1">[7]</xref>
###xml 532 535 532 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002407-Yamagishi1">[8]</xref>
###xml 588 591 588 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002407-Ariizumi1">[9]</xref>
###xml 603 606 603 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002407-Alsan1">[4]</xref>
###xml 1102 1106 1102 1106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002407-Gavert1">[10]</xref>
###xml 1108 1112 1108 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002407-Chien1">[11]</xref>
###xml 1135 1139 1135 1139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002407-Pandur1">[12]</xref>
###xml 1141 1145 1141 1145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002407-Yamagishi2">[13]</xref>
###xml 1150 1160 1150 1160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 1163 1171 1163 1171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">wingless</italic>
###xml 1234 1240 1234 1240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tinman</italic>
###xml 1245 1255 1245 1255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 1290 1299 1290 1299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">armadillo</italic>
###xml 1304 1314 1304 1314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 1370 1374 1367 1371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002407-Park1">[14]</xref>
###xml 1659 1663 1647 1651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002407-Marvin1">[15]</xref>
###xml 1664 1668 1652 1656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002407-Olson1">[18]</xref>
###xml 1742 1749 1730 1737 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus</italic>
###xml 1749 1753 1737 1741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002407-Pandur1">[12]</xref>
###xml 1786 1790 1774 1778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002407-Terami1">[19]</xref>
###xml 1970 1974 1958 1962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002407-Marvin1">[15]</xref>
###xml 1975 1979 1963 1967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002407-Tzahor1">[17]</xref>
###xml 1150 1160 <span type="species:ncbi:7227">Drosophila</span>
###xml 1245 1255 <span type="species:ncbi:7227">Drosophila</span>
###xml 1304 1314 <span type="species:ncbi:7227">Drosophila</span>
###xml 1758 1764 <span type="species:ncbi:10090">murine</span>
The critical event in heart formation is commitment of mesodermal cells to a cardiomyogenic fate and their migration into anterolateral regions of the embryo during late gastrulation. In this process, morphogenic movements and cardiac fate determination are regulated by cytokines such as bone morphogenetic proteins (BMPs) [1]-[3], and fibroblast growth factors (FGFs) [4]-[7]. These secreted proteins from neighboring endoderm, ectoderm, and the mesoderm itself, play important roles in induction of cardiac transcription factors [8] and differentiation of cardiomyocytes in amphibians [9] and avians [4]. Cardiomyogenic signals, such as BMPs and FGFs, indeed activate expression of cardiac specific transcriptional factors (Csx/Nkx2.5, Gata4, Mef2c), and these transcriptional factors activate expression of circulating hormones (atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP)), and cardiac specific proteins (myosin heavy chain (MyHC), myosin light chain (MyLC)). Wnt family proteins, cysteine-rich, and secreted glycoproteins, have also been implicated in embryonic development [10], [11], and cardiomyogenesis [12], [13]. In Drosophila, 'wingless', a homologue of vertebrate Wnt is involved in expression of 'tinman', a Drosophila homologue of Csx/Nkx2.5, through 'armadillo', a Drosophila ortholog of beta-catenin, and drives heart development [14]. In vertebrates, however, Wnt1/3a, which activates the canonical Wnt/beta-catenin signaling pathway leading to stabilization of beta-catenin as a downstream molecule through inactivation of glycogen synthase kinase-3beta, inhibits cardiomyocytic differentiation from cardiac mesoderm [15]-[18]. Wnt11 promotes cardiac differentiation via the non-canonical pathway in Xenopus[12] and murine embryonic cell lines [19]. The secretion of Wnt inhibitors such as 'Cerberus', 'Dickkopf' and 'Crescent' by the anterior endoderm prevents Wnt3a secreted by the neural tube from inhibiting heart formation [15]-[17].
###end p 9
###begin p 10
###xml 303 307 303 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002407-Sharov1">[20]</xref>
In this study, we performed GeneChip analysis to identify multiple extracellular determinants, such as cytokines, cell membrane-bound molecules and matrix responsible for cardiomyogenic differentiation, and evaluated the statistical significance of differential gene expression by NIA array analysis () [20], a web-based tool for microarray data analysis. We found that Grem1 enhances the determined path to cardiomyogenesis in a stage-specific manner, and that inhibition of the BMP signaling pathway is, at least in part, involved in initial determination of Grem1-promoted cardiomyogenesis.
###end p 10
###begin title 11
Results
###end title 11
###begin title 12
GeneChip and statistical analysis
###end title 12
###begin p 13
###xml 219 226 219 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002407-g001">Fig. 1A</xref>
###xml 228 235 228 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002407-t001">Table 1</xref>
###xml 317 325 317 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002407-g001">Fig. 1B:</xref>
###xml 680 684 680 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002407-Sharov1">[20]</xref>
###xml 685 689 685 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002407-Sharov2">[22]</xref>
###xml 934 941 934 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002407-g001">Fig. 1B</xref>
###xml 99 104 <span type="species:ncbi:9606">human</span>
To identify cytokines and transcription factors responsible for cardiomyogenic differentiation, 69 human cells were analyzed, depending on gene expression levels, by GeneSpringGX software, and clustered into 30 groups (Fig. 1A, Table 1). Among the 30 groups, 21 groups included cells with a cardiomyogenic potential (Fig. 1B: red numbers). To identify genes specific for these groups, hierarchical clustering was employed, using the average distance method. Genes with the lowest average expression E(G1) within the cluster that can differentiate into cardiomyocytes and genes with the highest average expression E(G2) outside the cluster were identified, as previously described [20]-[22]. Genes which have E(G1)>E(G2) were estimated, using the False Discovery Rate (FDR<0.05). Grem1 was nominated as a cluster-specific cardiomyocyte-promoting gene in cells that could differentiate into cardiomyocytes following NIA array analysis (Fig. 1B). The gene expression profile reported in this paper has been deposited in the Gene Expression Omnibus (GEO) database (: accession no. GSE8481, GSM41342- GSM41344, and GSM201137- GSM201145).
###end p 13
###begin title 14
###xml 45 50 <span type="species:ncbi:9606">human</span>
Hierarchical clustering analysis on cultured human cells.
###end title 14
###begin p 15
###xml 557 562 557 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grem1</italic>
###xml 89 94 <span type="species:ncbi:9606">human</span>
(A) Hierarchical clustering analyzed by GeneSpring. Based on gene expression pattern, 69 human cells were clustered into 30 sub-groups. The raw data from the GeneChip analysis are available at the GEO database with accession number GSE8481, GSM41342- GSM41344, and GSM201137- GSM201145. (B) Hierarchical clustering analysis was performed by NIA array (), using averaged values of 30 sub-groups. Among the 30 groups, 21 groups included cells with a cardiomyogenic potential. To identify genes specific for these groups, hierarchical clustering was employed. Grem1 was nominated as a cluster-specific cardiomyocyte-promoting gene in cells that could differentiate into cardiomyocytes.
###end p 15
###begin title 16
###xml 3 8 <span type="species:ncbi:9606">human</span>
69 human cells clustered into 30 groups
###end title 16
###begin title 17
Cardiomyogenic differentiation of CL6 cells with Grem1 and DMSO
###end title 17
###begin p 18
###xml 122 130 122 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 252 259 252 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002407-g002">Fig. 2A</xref>
###xml 262 266 262 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002407-Naito1">[23]</xref>
###xml 384 391 384 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002407-g002">Fig. 2B</xref>
###xml 640 647 640 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002407-g002">Fig. 2A</xref>
###xml 657 665 657 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002407.s004">Movie S1</xref>
###xml 670 672 670 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002407.s005">S2</xref>
To investigate cardiomyogenic activity of Grem1, P19CL6 embryonal carcinoma cells (CL6 cells) were used for assessment of in vitro cardiomyogenic differentiation, since CL6 cells are reproducibly and stably induced into beating cardiomyocytes by DMSO (Fig. 2Aa) [23]. CL6 cells did not differentiate following exposure to Grem1 alone at concentrations of 63 or 125 ng/ml for 14 days (Fig. 2B). However, Grem1 dramatically promotes DMSO-induced cardiomyogenic differentiation at a concentration of 63 and 125 ng/ml; Grem1 (125 ng/ml) especially increased DMSO-induced cardiomyogenic differentiation of CL6 cells as assessed by beating area (Fig. 2Ab and B) (Movie S1 and S2, ).
###end p 18
###begin title 19
Grem1 enhanced cardiomyogenic differentiation in DMSO-induced CL6 cells.
###end title 19
###begin p 20
###xml 534 544 534 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Csx/Nkx2.5</italic>
###xml 546 551 546 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gata4</italic>
###xml 553 558 553 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mef2c</italic>
###xml 560 565 560 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hand2</italic>
###xml 589 592 589 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANP</italic>
###xml 594 597 594 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BNP</italic>
###xml 627 634 627 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MyLC-2a</italic>
###xml 636 643 636 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MyLC-2v</italic>
###xml 645 654 645 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-MyHC</italic>
###xml 668 672 665 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmp2</italic>
###xml 674 678 671 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmp4</italic>
###xml 680 684 677 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf8</italic>
###xml 686 691 683 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grem1</italic>
###xml 693 697 690 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wnt1</italic>
###xml 699 704 696 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wnt3a</italic>
###xml 706 711 703 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wnt5a</italic>
###xml 713 718 710 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wnt7a</italic>
###xml 720 725 717 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wnt11</italic>
###xml 728 735 725 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SM-MyHC</italic>
###xml 741 746 738 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gapdh</italic>
###xml 799 809 796 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Csx/Nkx2.5</italic>
###xml 811 816 808 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gata4</italic>
###xml 818 823 815 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mef2c</italic>
###xml 825 830 822 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hand2</italic>
###xml 832 835 829 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANP</italic>
###xml 837 840 834 837 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BNP</italic>
###xml 842 849 839 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MyLC-2a</italic>
###xml 851 858 848 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MyLC-2v</italic>
###xml 860 869 857 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-MyHC</italic>
###xml 871 875 865 869 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmp2</italic>
###xml 877 881 871 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmp4</italic>
###xml 883 888 877 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grem1</italic>
###xml 890 895 884 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wnt11</italic>
###xml 897 904 891 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SM-MyHC</italic>
###xml 910 915 904 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gapdh</italic>
###xml 961 965 955 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf8</italic>
###xml 1016 1020 1010 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wnt1</italic>
###xml 1022 1027 1016 1021 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wnt3a</italic>
###xml 1029 1034 1023 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wnt5a</italic>
###xml 1040 1045 1034 1039 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wnt7a</italic>
###xml 1086 1087 1080 1081 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 769 774 <span type="species:ncbi:10090">Mouse</span>
###xml 923 928 <span type="species:ncbi:10090">mouse</span>
###xml 976 981 <span type="species:ncbi:10090">mouse</span>
(A) Phase contrast micrograph of CL6 cells with exposure to DMSO alone (a), Grem1 (125 ng/ml) and DMSO (b) for 14 days. The medium, including Grem1 and DMSO, was changed every day. CL6 cells exhibited apparent spontaneous beating between days 9-11. Beating CL6 cell colonies are outlined by white lines. (B) Percentage of beating area in differentiated CL6 cells. CL6 cell treated with Grem1 (125 ng/ml) and DMSO exhibited the strongest contraction. (C) RT-PCR analysis of the genes encoding cardiac-specific transcriptional factors (Csx/Nkx2.5, Gata4, Mef2c, Hand2), circulating hormone (ANP, BNP), cardiac-specific proteins (MyLC-2a, MyLC-2v, beta-MyHC), cytokines (Bmp2, Bmp4, Fgf8, Grem1, Wnt1, Wnt3a, Wnt5a, Wnt7a, Wnt11), SM-MyHC, and Gapdh (From top to bottom). Mouse total heart RNA for the Csx/Nkx2.5, Gata4, Mef2c, Hand2, ANP, BNP, MyLC-2a, MyLC-2v, beta-MyHC, Bmp2, Bmp4, Grem1, Wnt11, SM-MyHC, and Gapdh genes, mouse embryonic stem cell RNA for the Fgf8 gene, and mouse total skeletal muscle RNA for the Wnt1, Wnt3a, Wnt5a, and Wnt7a genes were used for positive controls. H2O (without RNA) served as a negative control. (D) Immunocytochemistry of CL6 cells 14 days after exposure to Grem1 (125 ng/ml) and DMSO with MF20 and cTnT (a), and alpha-actinin (b). Cell nuclei are stained with DAPI. Clear striations are evident. (E) Immunocytochemistry of CL6 cells 14 days after exposure to Grem1 and DMSO with cardiac troponin T (cTnT) and sarcomeric myosin (MF20). CL6 cells treated with Grem1 (125 ng/ml) and DMSO (a), and DMSO alone (b) stained positive for cTnT and MF20. Untreated CL6 cells, i.e. not exposed to Grem1(125 ng/ml) or DMSO, stained negative for cTnT and MF20. Cell nuclei were stained with DAPI. (F) Percentage of MF20- and cTnT-double positive area.
###end p 20
###begin title 21
RT-PCR of differentiated or undifferentiated CL6 cells
###end title 21
###begin p 22
###xml 251 258 251 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002407-g002">Fig. 2C</xref>
###xml 276 286 276 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Csx/Nkx2.5</italic>
###xml 288 293 288 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gata4</italic>
###xml 295 300 295 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hand2</italic>
###xml 302 307 302 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mef2c</italic>
###xml 309 312 309 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANP</italic>
###xml 314 317 314 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BNP</italic>
###xml 319 326 319 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MyLC-2a</italic>
###xml 328 335 328 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MyLC-2v</italic>
###xml 341 350 341 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-MyHC</italic>
###xml 449 457 446 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002407-g002">Fig. 2C:</xref>
###xml 640 650 637 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Csx/Nkx2.5</italic>
###xml 652 657 649 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gata4</italic>
###xml 659 666 656 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MyLC-2a</italic>
###xml 668 675 665 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MyLC-2v</italic>
###xml 851 860 848 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002407.s001">Figure S1</xref>
To investigate gene expression as well as morphological analysis, i.e. beating, during cardiomyogenic differentiation, RT-PCR analysis was performed to detect expression of cardiomyocyte-specific/associate transcription factors, and structural genes (Fig. 2C). Genes encoding Csx/Nkx2.5, Gata4, Hand2, Mef2c, ANP, BNP, MyLC-2a, MyLC-2v, and beta-MyHC were up-regulated during cardiomyogenic differentiation of CL6 cells treated with Grem1 and DMSO (Fig. 2C: lanes 6, 7 versus lane 3). Triplicate independent experiments confirmed the concentration-dependent Grem1 action on cardiomyogenic differentiation. The cardiomyocyte-specific genes (Csx/Nkx2.5, Gata4, MyLC-2a, MyLC-2v) expression level of CL6 cells treated with DMSO and Grem1 (63 and 125 ng/ml) were also the same as or higher than that of DMSO-induced CL6 cells by semi-quantitative RT-PCR (Figure S1).
###end p 22
###begin title 23
Immunocytochemistry of differentiated or undifferentiated CL6 cells
###end title 23
###begin p 24
###xml 232 239 228 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002407-g002">Fig. 2D</xref>
###xml 333 340 329 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002407-g002">Fig. 2E</xref>
###xml 398 405 394 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002407-g002">Fig. 2E</xref>
###xml 571 578 567 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002407-g002">Fig. 2F</xref>
###xml 599 606 595 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002407-g002">Fig. 2B</xref>
###xml 671 678 667 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002407-g002">Fig. 2F</xref>
To examine CL6 cells for expression of cardiomyocytic protein, immunocytochemical analysis was performed. CL6 treated with Grem1 (125 ng/ml) and DMSO exhibited clear striation with immunostain using anti-cTnT or anti-alpha-actinin (Fig. 2Da and b). The MF20- and cTnT-positive cells after exposure to Grem1 and DMSO formed clusters (Fig. 2Ea), compared with the cells after exposure to DMSO alone (Fig. 2Eb). CL6 cells treated with Grem1 alone were negative for MF20 and cTnT, but became positive for both markers following exposure to Grem1 (63 and 125 ng/ml) and DMSO (Fig. 2F). The beating area (Fig. 2B) showed a tendency similar to the MF20- and cTnT-positive area (Fig. 2F), thus there were positive correlations between them.
###end p 24
###begin title 25
Grem1 and DMSO were most effective at the early stage (days 1-3) of CL6 differentiation
###end title 25
###begin p 26
###xml 161 168 161 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002407-g003">Fig. 3A</xref>
###xml 242 252 242 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002407-g003">Fig. 3B, C</xref>
###xml 370 374 370 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002407-Hsu1">[24]</xref>
###xml 580 590 580 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BrachyuryT</italic>
###xml 595 599 595 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tbx6</italic>
###xml 648 658 648 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Csx/Nkx2.5</italic>
###xml 679 688 679 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-MyHC</italic>
###xml 695 700 692 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gapdh</italic>
###xml 702 709 699 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002407-g004">Fig. 4A</xref>
###xml 729 739 726 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BrachyuryT</italic>
###xml 744 748 741 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tbx6</italic>
###xml 878 888 875 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Csx/Nkx2.5</italic>
###xml 893 902 890 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-MyHC</italic>
###xml 1104 1114 1098 1108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Csx/Nkx2.5</italic>
###xml 1119 1128 1113 1119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-MyHC</italic>
###xml 1136 1143 1127 1134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002407-g004">Fig. 4A</xref>
To determine if Grem1 (125 ng/ml) functions during the early or the late stage of differentiation, CL6 cells were treated with Grem1 for different time periods (Fig. 3A). Grem1 and DMSO were most effective on CL6 differentiation at 1-3 days (Fig. 3B, C) as assessed by percentages of MF20-positive area and beating area. Since Grem1 inhibits BMPs through direct binding [24], we hypothesized that BMP signaling is inhibitory to CL6 cardiomyogenesis during days 1-3. To confirm this hypothesis, RT-PCR analysis was performed to determine expression of the early mesodermal marker (BrachyuryT and Tbx6), cardiomyocyte-specific transcription factors (Csx/Nkx2.5), structural genes (beta-MyHC), and Gapdh (Fig. 4A). DMSO induced the BrachyuryT and Tbx6 genes, and their expressions peaked at 3 days and then decreased; BMP2 down-regulated expression of these genes at 3-7 days. The Csx/Nkx2.5 and beta-MyHC genes started to be expressed at days 3 and 5, respectively, and their expression increased up to 14 days, at which time the timeframe analysis was terminated. BMP2 clearly inhibited expression of the Csx/Nkx2.5 and beta-MyHC genes (Fig. 4A, lanes 1-7 versus lanes 8-14).
###end p 26
###begin title 27
Percentage of myogenic differentiation by period of treatment with Grem1 in CL6 cells.
###end title 27
###begin p 28
###xml 79 80 79 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
(A) Protocol for treatment of Grem1 and DMSO. CL6 cells were passaged at 1.8x105 cells in 6-well plate on Day 0. CL6 cells were exposed to Grem1 (125 ng/ml) and/or DMSO on the indicated day. Day when the cells were exposed to the inducers is shown by "+" (in gray cells for clarity). The medium including Grem1 and DMSO was changed every day. On day 14, the cells were immunocytochemically stained with MF20 antibody. (B) Myogenic differentiation of CL6 cells was estimated by sarcomeric myosin (MF20)-positive area. CL6 cells were treated with Grem1 (125 ng/ml) and DMSO for the indicated days. (C) Myogenic differentiation of CL6 cells was estimated by beating area. CL6 cells treated with DMSO and Grem1 (125 ng/ml) were incubated at indicated days.
###end p 28
###begin p 29
###xml 331 338 331 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002407-g004">Fig. 4B</xref>
###xml 420 424 420 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmp2</italic>
###xml 429 433 429 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmp4</italic>
###xml 493 500 493 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002407-g004">Fig. 4C</xref>
###xml 528 532 528 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmp2</italic>
###xml 537 541 537 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmp4</italic>
###xml 623 627 623 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmp2</italic>
###xml 658 666 658 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002407-g004">Fig. 4C:</xref>
###xml 666 670 666 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmp2</italic>
###xml 711 715 711 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmp4</italic>
###xml 745 753 745 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002407-g004">Fig. 4C:</xref>
###xml 753 757 753 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmp4</italic>
To examine cardiomyogenic differentiation, immunocytochemical analysis was performed on CL6 cells treated with the inducers. CL6 cells treated with DMSO and BMP2 for the first 3 days were negative for sarcomeric myosin (MF20) at 14 days, but became positive for sarcomeric myosin, following exposure to DMSO alone during days 1-3 (Fig. 4B). To determine if DMSO induces BMP production in CL6 cells, expression levels of Bmp2 and Bmp4 were determined by quantitative real-time RT-PCR analysis (Fig. 4C). DMSO clearly induced the Bmp2 and Bmp4 genes, and DMSO-induction was inhibited by BMP2 protein. The expression level of Bmp2 was highest during days 7-10 (Fig. 4C:Bmp2) in DMSO-induced CL6 cells, and that of Bmp4 was highest during days 5-7 (Fig. 4C:Bmp4).
###end p 29
###begin title 30
Cardiomyogenic differentiation in CL6 cells (days 1-3) is inhibited by BMP2.
###end title 30
###begin p 31
###xml 41 51 41 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BrachyuryT</italic>
###xml 53 57 53 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tbx6</italic>
###xml 100 109 100 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Csx/Nkx2.</italic>
###xml 139 148 139 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-MyHC</italic>
###xml 155 160 152 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gapdh</italic>
###xml 589 590 586 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 662 666 659 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmp2</italic>
###xml 679 683 676 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmp4</italic>
###xml 1032 1035 1029 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Id1</italic>
###xml 1376 1381 1373 1378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wnt3a</italic>
###xml 2068 2069 2062 2063 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1126 1129 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1847 1850 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
(A) RT-PCR analysis of the gene encoding BrachyuryT, Tbx6, cardiac-specific transcriptional factor (Csx/Nkx2.5), cardiac-specific protein (beta-MyHC), and Gapdh (From top to bottom) of CL6 cells treated with DMSO alone, or DMSO and BMP2 (100 ng/ml) for the first 3 days (days 1-3). The medium, including BMP2 and DMSO, was changed every day. (B) Percentage of MF20-positive area. Immunocytochemistry was carried out on CL6 cells 14 days after cells had been exposed to DMSO and BMP2 (100 ng/ml) for the first 3 days (days 1-3). The asterisk indicates a significant statistical difference (P<0.05). (C) Quantitative real-time RT-PCR analysis of the gene encoding Bmp2 (left), and Bmp4 (right) in CL6 cells treated with DMSO alone (open square), or DMSO and BMP2 (100 ng/ml) (closed square) for the first 3 days (days 1-3). (D) BMP signaling activity of CL6 cells treated with DMSO alone (open square), or DMSO and BMP2 (100 ng/ml) (closed square) for the first 3 days (days 1-3) were determined by luciferase activity analysis using Id1 promoter-Lux (a firefly luciferase reporter plasmid driven by the Id1 binding sites), pRL-CMV as co-transfected control, and Dual luciferase reporter assay system. Relative luciferase unit of the CL6 cells untreated with inducers at day 3 is regarded as 0.1 (data not shown). (E) Quantitative real-time RT-PCR analysis of the gene encoding Wnt3a in CL6 cells treated with DMSO alone (open square), or DMSO and BMP2 (100 ng/ml) (closed square) for the first 3 days (days 1-3). (F) Wnt/beta-catenin signaling activity of CL6 cells 48 h after exposure to DMSO, or DMSO and BMP2 (100 ng/ml) was determined by luciferase activity analysis using TOPflash (a firefly luciferase reporter plasmid driven by two sets of three copies of the TCF binding site and herpes simple virus thymidine kinase minimal promoter), pRL-CMV as co-transfected control, and Dual luciferase reporter assay system. Relative luciferase unit of the CL6 cells untreated with inducers is regarded as 0.1. The asterisk indicates a significant statistical difference (P<0.05). (G) Timeframe of Wnt/beta-catenin signaling activity in CL6 cells treated with DMSO alone (open square), or DMSO and BMP2 (100 ng/ml) (closed square) for the first 3 days (days 1-3). Relative luciferase unit of the CL6 cells untreated with inducers at day 3 is regarded as 0.1 (data not shown).
###end p 31
###begin p 32
###xml 76 79 76 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Id1</italic>
###xml 149 152 149 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Id1</italic>
###xml 195 202 195 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002407-g004">Fig. 4D</xref>
###xml 266 273 266 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002407-g004">Fig. 4D</xref>
###xml 346 353 346 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002407-g004">Fig. 4D</xref>
To investigate BMP signaling on cardiomyogenic differentiation, we used the Id1 promoter-Lux plasmid that includes the luciferase gene driven by the Id1 promoter, known as a BMP target promoter (Fig. 4D). DMSO increased BMP signaling activity that peaked at 5 days (Fig. 4D, open square). BMP2 protein increased BMP signaling activity at 3 days (Fig. 4D, closed square), but lost BMP signaling activity at 5 days and later, implying that this loss of BMP signaling leads to lack of cardiomyogenic induction.
###end p 32
###begin p 33
###xml 69 73 66 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002407-Naito1">[23]</xref>
###xml 75 79 72 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002407-Naito2">[25]</xref>
###xml 339 344 333 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wnt3a</italic>
###xml 366 373 360 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002407-g004">Fig. 4E</xref>
###xml 406 410 400 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002407-Naito1">[23]</xref>
###xml 730 737 718 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002407-g004">Fig. 4F</xref>
###xml 866 873 851 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002407-g004">Fig. 4G</xref>
Since Wnt/beta-catenin signaling is involved in CL6 cardiomyogenesis [23], [25], we hypothesized that the BMP effect on CL6 cardiomyogenesis is mediated through Wnt/beta-catenin signaling. Expression of Wnt3a, an activator of canonical Wnt signaling, was indeed detected in CL6 cells exposed to DMSO, and BMP2 significantly down-regulated Wnt3a expression at day 3 (Fig. 4E). By using the TOPflash plasmid [23] which includes the luciferase gene driven by two sets of three copies of the TCF recognition site, Wnt/beta-catenin signaling was assessed to investigate the effect of BMP2. Wnt/beta-catenin signaling activity increased at 48 h after treatment with DMSO. Activity was increased by DMSO treatment but decreased by BMP2 (Fig. 4F). Time course analysis revealed that Wnt/beta-catenin activity peaked at 5 days after DMSO treatment, and decreased thereafter (Fig. 4G). BMP2 inhibited DMSO-induced Wnt/beta-catenin activity throughout the experimental period (up to 14 days). These results imply that BMP signaling inhibits CL6 cardiomyogenesis at the early stage through inhibition of Wnt/beta-catenin signaling.
###end p 33
###begin title 34
Discussion
###end title 34
###begin p 35
###xml 548 554 545 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002407-g005">Fig. 5</xref>
###xml 752 756 746 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002407-Jin1">[26]</xref>
###xml 87 92 <span type="species:ncbi:9606">human</span>
Our bioinformatics study using the results from the global gene expression analysis of human cells (GSM412342-41344 and GSM201137-201145 at ) nominated Grem1 as a candidate gene that may participate in cardiomyogenesis. By using CL6 embryonic cells as a model of cardiomyogenesis, we obtained two major findings: the first is that Grem1 enhanced cardiomyogenic differentiation of DMSO-induced CL6 cells at the early stage; the second is that Wnt/beta-catenin and BMP signaling activity had developmental stage-specific effects on cardiomyogenesis (Fig. 5). Wnt/beta-catenin activity at the early stage enhanced embryonic cell differentiation into cardiomyocytes, while suppressing this activity by BMP2 or BMP4 proteins as reported in the avian embryo [26]. In contrast, BMP signaling activity in the late stage enhanced cardiomyocytic differentiation. Grem1 regulated the stage-specific Wnt/beta-catenin and BMP signaling activity on cardiomyogenesis.
###end p 35
###begin title 36
Grem1-accelerated CL6 cardiomyogenesis through regulation of BMP- and Wnt/beta-catenin-signaling pathways.
###end title 36
###begin p 37
CL6 embryonic cells start to differentiate into mesodermal cells through Wnt/beta-catenin signaling pathway at the early stage (days 1-3), and mesodermal CL6 cells differentiate into mature cardiomyocytes by BMP pathway at the late stage (days 4-14). Grem1 accelerates DMSO-induced cardiomyogenesis through inhibition of the BMP-signaling pathway.
###end p 37
###begin p 38
###xml 113 117 113 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002407-Sutherland1">[27]</xref>
###xml 138 142 138 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002407-Shi1">[28]</xref>
###xml 155 159 155 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002407-Tzahor2">[29]</xref>
###xml 180 184 180 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002407-Zuniga1">[30]</xref>
###xml 308 312 308 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002407-Michos1">[31]</xref>
###xml 425 429 425 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002407-Yuasa1">[32]</xref>
###xml 545 553 545 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 652 656 652 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002407-Singh1">[33]</xref>
###xml 831 844 831 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002407-g002">Fig. 2C and F</xref>
###xml 1054 1057 1054 1057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002407-Angello1">[3]</xref>
###xml 1234 1238 1234 1238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002407-Frank1">[34]</xref>
###xml 1347 1360 1347 1360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002407-g002">Fig. 2E and F</xref>
###xml 234 238 <span type="species:ncbi:10090">mice</span>
Many studies have indicated that Grem1 is involved in cell differentiation and development, such as osteogenesis [27], lung morphogenesis [28], myogenesis [29], and limb formation [30], through inhibition of BMP2 and BMP4. Grem1-null mice show intact heart development, despite impairment of lung and kidney [31], and therefore Grem1 is considered not to be involved in cardiogenesis, or supplementary factors such as Noggin [32], with a similar function, may compensate Grem1 during development. Grem1 had an enhancing or promoting activity in in vitro cardiomyogenesis, as is the case with platelet-derived growth factor as a promoter of cell growth [33]. In this study, Grem1 was involved in cardiomyocyte differentiation. However Grem1 alone could not induce cardiomyocytic differentiation of CL6 cells in the absence of DMSO (Fig. 2C and F), suggesting that Grem1 is solely a promoter of cardiomyogenic differentiation. One of the possible mechanisms for Grem1-enhanced cardiomyogenesis at the early stage is inhibition of the BMP signaling pathway [3]. Alternatively, Grem1-enhanced cardiomyogenesis may be mediated through proliferation of cardiac progenitor cells, as is the case of myogenic progenitor proliferation by Grem1 [34], and this possibility is supported by an increased number of sarcomeric myosin-positive CL6 cardiomyocytes (Fig. 2E and F).
###end p 38
###begin p 39
###xml 196 204 193 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 204 208 201 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002407-Naito2">[25]</xref>
###xml 213 220 210 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 220 224 217 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002407-Klaus1">[35]</xref>
###xml 708 714 702 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002407-g005">Fig. 5</xref>
###xml 716 725 710 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002407.s002">Figure S2</xref>
###xml 838 848 829 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002407-g004">Fig. 4F, G</xref>
###xml 885 895 876 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BrachyuryT</italic>
###xml 900 904 891 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tbx6</italic>
###xml 912 919 903 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002407-g004">Fig. 4A</xref>
###xml 976 980 964 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002407-Yamaguchi1">[36]</xref>
###xml 1060 1064 1045 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002407-Kleber1">[37]</xref>
The stage specificity of the Grem1 effect is possibly correlated with the biphasic and antagonistic effect of Wnt/beta-catenin signaling on cardiomyogenesis, depending on the stage of development in vitro[25] and in vivo[35]. CL6 cells differentiated into cardiomyocytes via mesodermal induction by the Wnt/beta-catenin signaling pathway at the early stage, and CL6 mesodermal cells differentiated into cardiomyocytes induced by BMP2 at the late stage. It is conceivable that embryonic cells, such as CL6 cells and ES cells, differentiate into cardiomyocytes by inhibiting BMP signaling via putative "mesodermal cells" or "cardiomyogenic progenitors", or differentiation stages corresponding to these cells (Fig. 5, Figure S2). The early stage process from embryonic cells to mesodermal cells was mediated via Wnt/beta-catenin signaling (Fig. 4F, G), and was assessed by expression of BrachyuryT and Tbx6 genes (Fig. 4A), which are target genes for Wnt/beta-catenin signaling [36]. BMP signaling antagonizes the cell fate-inducing activity of Wnt/beta-catenin [37]. When embryonic cells or cardiomyogenic progenitors are induced to become mature cardiomyocytes by cytokines and growth factors, we must be careful with respect to the stage of cell differentiation because of the biphasic differential action of the factors which are dependent upon the differentiation stage.
###end p 39
###begin p 40
###xml 374 379 374 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grem1</italic>
###xml 489 494 <span type="species:ncbi:9606">human</span>
In conclusion, we have demonstrated that Grem1 enhances the commitment or determined path to cardiogenic differentiation of CL6 teratocarcinoma cells. Apart from a role in development, Grem1 may serve a clinical use in cardiology, like granulocyte colony-stimulating factor that accelerates production of granulocytes in both peripheral blood and bone marrow. Nomination of Grem1 as a cardiomyogenic factor is based on hierarchical clustering analysis using global gene expression data of human cells. This bioinformatics approach may be useful for identifying morphogens/factors that can induce differentiation of other cell types/tissues/organs.
###end p 40
###begin title 41
Materials and Methods
###end title 41
###begin title 42
GeneChip analysis
###end title 42
###begin p 43
###xml 33 40 33 40 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002407-g001">Fig. 1A</xref>
###xml 42 49 42 49 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002407-t001">Table 1</xref>
###xml 75 79 75 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002407-Sugiki1">[38]</xref>
###xml 81 86 <span type="species:ncbi:9606">Human</span>
###xml 137 142 <span type="species:ncbi:9606">Human</span>
GeneChip analysis was performed (Fig. 1A, Table 1) as previously described [38]. Human genome-wide gene expression was examined with the Human Genome U133A Probe array (GeneChip; Affymetrix), which contains the oligonucleotide probe set for approximately 23,000 full-length genes and expressed sequence tags, according to the manufacturer's protocol (Expression Analysis technical manual and GeneChip Small Sample Target Labeling Assay version 2 technical note []). Data analysis was performed by the GeneChip Operation System (Affymetrix) and GeneSpringGX software (Silicon Genetics). To normalize the staining intensity variations between chips, the average difference values for all genes on a given chip were divided by the median of all measurements on that chip. Hierarchical-clustering analysis was performed using a minimum distance value of 0.001, a separation ratio of 0.5, and the standard definition of the correlation distance.
###end p 43
###begin title 44
Cell culture and differentiation
###end title 44
###begin p 45
###xml 209 210 205 206 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 308 309 298 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 106 112 <span type="species:ncbi:9913">bovine</span>
###xml 526 531 <span type="species:ncbi:9606">human</span>
CL6 cells were grown on 100 mm dishes (Becton Dickinson) in alpha-MEM (Gibco) supplemented with 10% fetal bovine serum (FBS) (JRH Bioscience, Inc.), penicillin, and streptomycin, and were maintained in a 5% CO2 atmosphere at 37degreesC. To induce differentiation, CL6 cells were plated at a density of 1.8x105 cells in a 6-well plate (Becton Dickinson) or gelatin-coated 35 mm glass base dishes (IWAKI) with alpha-MEM containing Grem1 (63 or 125 ng/ml: R&D system) and/or 1% dimethyl sulfoxide (DMSO) for 14 days. Recombinant human bone morphogenetic protein-2 (BMP2) was purchased from R&D systems.
###end p 45
###begin title 46
Reverse transcriptase-PCR (RT-PCR) and quantitative real-time RT-PCR analysis
###end title 46
###begin p 47
###xml 807 817 794 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Csx/Nkx2.5</italic>
###xml 819 824 806 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gata4</italic>
###xml 826 831 813 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mef2c</italic>
###xml 833 838 820 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hand2</italic>
###xml 861 864 848 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANP</italic>
###xml 866 869 853 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BNP</italic>
###xml 900 909 887 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-MyHC</italic>
###xml 911 918 895 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MyLC-2a</italic>
###xml 920 927 904 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MyLC-2v</italic>
###xml 940 944 924 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmp2</italic>
###xml 946 950 930 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmp4</italic>
###xml 952 956 936 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf8</italic>
###xml 958 963 942 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grem1</italic>
###xml 965 969 949 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wnt1</italic>
###xml 971 976 955 960 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wnt3a</italic>
###xml 978 983 962 967 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wnt5a</italic>
###xml 985 990 969 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wnt7a</italic>
###xml 992 997 976 981 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wnt11</italic>
###xml 1067 1074 1051 1058 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SM-MyHC</italic>
###xml 1106 1124 1090 1108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BrachyuryT, T-box6</italic>
###xml 1126 1130 1110 1114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tbx6</italic>
###xml 1137 1142 1121 1126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gapdh</italic>
###xml 1550 1560 1492 1502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Csx/Nkx2.5</italic>
###xml 1562 1567 1504 1509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gata4</italic>
###xml 1569 1574 1511 1516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mef2c</italic>
###xml 1576 1581 1518 1523 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hand2</italic>
###xml 1583 1586 1525 1528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANP</italic>
###xml 1588 1591 1530 1533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BNP</italic>
###xml 1593 1602 1535 1541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-MyHC</italic>
###xml 1604 1611 1543 1550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MyLC-2a</italic>
###xml 1613 1620 1552 1559 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MyLC-2v</italic>
###xml 1622 1626 1561 1565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmp2</italic>
###xml 1628 1632 1567 1571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmp4</italic>
###xml 1634 1638 1573 1577 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgf8</italic>
###xml 1640 1645 1579 1584 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grem1</italic>
###xml 1647 1651 1586 1590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wnt1</italic>
###xml 1653 1658 1592 1597 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wnt3a</italic>
###xml 1660 1665 1599 1604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wnt5a</italic>
###xml 1667 1672 1606 1611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wnt7a</italic>
###xml 1674 1679 1613 1618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wnt11</italic>
###xml 1681 1688 1620 1627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SM-MyHC</italic>
###xml 1690 1700 1629 1639 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BrachyuryT</italic>
###xml 1702 1706 1641 1645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tbx6</italic>
###xml 1712 1717 1651 1656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gapdh</italic>
###xml 1719 1728 1658 1667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002407.s003">Table S1a</xref>
###xml 81 86 <span type="species:ncbi:10090">mouse</span>
###xml 165 170 <span type="species:ncbi:10090">Mouse</span>
###xml 198 203 <span type="species:ncbi:10090">mouse</span>
###xml 235 240 <span type="species:ncbi:10090">mouse</span>
###xml 1749 1754 <span type="species:ncbi:10090">Mouse</span>
Total RNAs were extracted from differentiated and undifferentiated CL6 cells and mouse embryonic stem (ES) cells with RNeasy minikit and DNase I treatment (QIAGEN). Mouse ES cell (129 strains) RNA, mouse heart total RNA (Clontech) and mouse skeletal muscle/total RNA (UNITECH. Co., Ltd.) were used as a positive control for each primer. Total RNA (2.0 microg each) for RT-PCR was converted to cDNA with Superscripttrade mark III RNase H- reverse transcriptase (Invitrogen), according to the manufacturer's manual. PCR conditions were optimized and linear amplification range was determined for each primer by varying annealing temperature and cycle number. PCR products were identified by positive control size. RT-PCR was performed using the primers of the genes of cardiac specific transcription factors: Csx/Nkx2.5, Gata4, Mef2c, Hand2; circulating hormone: ANP, BNP; cardiac structural proteins: beta-MyHC, MyLC-2a, MyLC-2v; cytokines: Bmp2, Bmp4, Fgf8, Grem1, Wnt1, Wnt3a, Wnt5a, Wnt7a, Wnt11; smooth muscle structural protein: smooth muscle-myosin heavy chain (SM-MyHC); the early mesodermal marker: BrachyuryT, T-box6 (Tbx6); and Gapdh as control. PCR was performed with exTaq DNA polymerase and exTaq PCR buffer (TaKaRa) or LATaq DNA polymerase and GC buffer I (TaKaRa) for 25 or 30 cycles, with each cycle consisting of 95degreesC for 30 s, 50degreesC, 55degreesC, 60degreesC or 65degreesC for 45 s, and 72degreesC for 45 s, with an additional 5 min incubation at 72degreesC after completion of the final cycle. PCR primers for the genes of Csx/Nkx2.5, Gata4, Mef2c, Hand2, ANP, BNP, beta-MyHC, MyLC-2a, MyLC-2v, Bmp2, Bmp4, Fgf8, Grem1, Wnt1, Wnt3a, Wnt5a, Wnt7a, Wnt11, SM-MyHC, BrachyuryT, Tbx6, and Gapdh (Table S1a) were obtained from Mouse Genome Informatics (). The PCR products were size-fractionated by 2% agarose gel electrophoresis.
###end p 47
###begin p 48
###xml 284 288 276 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmp2</italic>
###xml 290 294 282 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmp4</italic>
###xml 296 301 288 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wnt3a</italic>
###xml 307 312 299 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gapdh</italic>
###xml 314 323 306 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002407.s003">Table S1b</xref>
Quantitative real-time RT-PCR was performed on an ABI Prism 7700 Sequence Detection System (Applied Biosystems), using 100 ng of cDNA in 25 microl reaction volume with 10 nmol/l of each primer, and 12.5 microl SYBR Green Realtime PCR Master Mix (TOYOBO). PCR primers for the genes of Bmp2, Bmp4, Wnt3a, and Gapdh (Table S1b) were obtained from PrimerBank (). Calculations were automatically performed by ABI software (Applied BioSystems).
###end p 48
###begin title 49
Immunocytochemistry
###end title 49
###begin p 50
###xml 559 561 553 555 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2b</sub>
###xml 684 685 678 679 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 807 808 793 794 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 979 981 959 961 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2b</sub>
###xml 1074 1075 1054 1055 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 403 407 <span type="species:ncbi:9925">goat</span>
###xml 550 555 <span type="species:ncbi:10090">mouse</span>
###xml 675 680 <span type="species:ncbi:10090">mouse</span>
###xml 798 803 <span type="species:ncbi:10090">mouse</span>
###xml 960 964 <span type="species:ncbi:9925">goat</span>
###xml 970 975 <span type="species:ncbi:10090">Mouse</span>
###xml 1055 1059 <span type="species:ncbi:9925">goat</span>
###xml 1065 1070 <span type="species:ncbi:10090">mouse</span>
###xml 1149 1153 <span type="species:ncbi:9925">goat</span>
###xml 1159 1164 <span type="species:ncbi:10090">mouse</span>
A laser confocal microscope (LSM510, Zeiss) was used for immunocytochemical analysis. Differentiated and undifferentiated CL6 cells were fixed with 4% paraformaldehyde (Wako) for 5 min at 4degreesC and treated with 0.1% triton X-100 (Sigma) in PBS for 20 min at room temperature, then incubated for 20 min at room temperature in a protein-blocking solution consisting of PBS supplemented with 5% normal goat serum (DakoCytomation). These CL6 cells were then incubated overnight with primary antibody monoclonal anti-sarcomeric myosin antibody (MF20, mouse IgG2b isotype, 1 mg/ml, University of Iowa Hybridoma Bank) and Troponin T, and Cardiac Isoform Ab-1 clone 13-11 (cTnT, mouse IgG1 isotype, 1:300, Lab Vision Corp), or the monoclonal anti-alpha-actinin (SARCOMERIC) CLONE EA-53 (alpha-actinin, mouse IgG1 isotype, 1:300, Sigma) in PBS at 4degreesC. The cells were extensively washed in PBS and incubated at room temperature with Alexa Fluor 568-conjugated goat anti-Mouse IgG2b (anti-MF20) (Molecular Probe; diluted 1:300), Alexa Fluor 488-conjugated goat anti-mouse IgG1 (anti-cTnT) (Molecular Probe; diluted 1:300), Alexa Fluor 546-conjugated goat anti-mouse IgG(H+L) (anti-alpha-actinin) (Molecular Probe; diluted 1:300), and nuclei were counterstained with 4', 6-diamidino-2-phenylindole (DAPI) (Wako; diluted 1:300) for 45 min. To prevent fading, cells were then mounted in DakoCytomation Fluorescent Mounting Medium (DakoCytomation).
###end p 50
###begin title 51
Transfection and luciferase assays
###end title 51
###begin p 52
###xml 13 14 13 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 341 344 330 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Id1</italic>
###xml 438 441 427 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Id1</italic>
###xml 615 616 600 601 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 484 487 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Cells (8.0x105) seeded and cultured in 60 mm dishes (Becton Dickinson) were transfected 18 h after plating using Lipofectamine 2000 (Invitrogen) and PLUS reagent (Invitrogen) in Opti-MEM (Gibco). Transfection contained 1.0 microg of TOPflash plasmid (Upstate Biotechnology) for measurement of Wnt/beta-catenin activity, or 5.0 microg of the Id1 promoter-Lux plasmid (provided by Dr Imamura and Dr Miyazono) for measurement of BMP-induced Id1 gene transcription, and 0.5 microg of pRL-CMV (Promega) as co-transfected control. Medium containing 10% FBS was changed 3 h after transfection and transfected cells (1.8x105) were re-seeded in 6-well plates 24 h after transfection. After 18 h, CL6 cells were induced with BMP2 (100 ng/ml) and DMSO. CL6 cells were prepared for luciferase activity analysis using Dual luciferase reporter assay system (Promega).
###end p 52
###begin title 53
Area calculation
###end title 53
###begin p 54
The regions of interest (beating area, immunostaining area) were defined in Photoshop (Adobe systems) using the 'magic wand' tool. The total numbers of pixels identified were then counted using the histogram function. At least five different fields were measured for each dish.
###end p 54
###begin title 55
Statistical analysis
###end title 55
###begin p 56
###xml 89 90 87 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Results, shown as the mean+/-SE, were compared by ANOVA followed by Scheffe's test, with P<0.05 considered significant.
###end p 56
###begin title 57
Supporting Information
###end title 57
###begin p 58
A semi-quantitative RT-PCR of cardiomyocyte-specific genes. To investigate expression level of cardiomyocyte-specific genes (Csx/Nkx2.5, Gata4, MyLC-2a, and MyLC-2v), a semi-quantitative RT-PCR was performed from CL6 cells treated with 1% DMSO and the indicated concentration of Grem1 for 14 days. Each RT-PCR product was electrophoresed in 2% agarose gel, and was measured using ImageJ software () to calculate the ratio of each gene to Gapdh. The expression level for each gene is determined relative to that of Gapdh, and expression level in CL6 cells treated with DMSO alone was regarded as 1.0. The relative expression levels were averaged from at least three independent experiments.
###end p 58
###begin p 59
(1.04 MB DOC)
###end p 59
###begin p 60
Click here for additional data file.
###end p 60
###begin p 61
###xml 49 54 <span type="species:ncbi:10090">mouse</span>
###xml 65 70 <span type="species:ncbi:10090">Mouse</span>
###xml 128 133 <span type="species:ncbi:10090">mouse</span>
###xml 331 337 <span type="species:ncbi:9913">bovine</span>
###xml 512 517 <span type="species:ncbi:10090">mouse</span>
Grem1 enhanced cardiomyogenic differentiation of mouse ES cells. Mouse ES cells (NCH1.5, C57BL/6Jx129ter/Sv) were cultured on a mouse embryonic fibroblast feeder layer inactivated with 30 Gy gamma-irradiation in gelatin-coated 60 mm dishes (Becton, Dickinson). Cells were grown in KnockOut DMEM (Gibco) supplemented with 15% fetal bovine serum (Cell Culture Technologies), 2 mM GlutaMAX (Gibco), 0.1 mM non-essential amino acid (Gibco), 0.1 mM 2-mercaptoethanol (Gibco), penicillin, streptomycin, and 2,000 U/ml mouse leukemia inhibitory factor (LIF) (Chemicon). For cardiomyogenic differentiation, ES cells were exposed to 125 ng/ml Grem1 (R&D systems) for the three days. The cells were then trypsinized and cultured to form embryonic bodies (EBs) from a single cell using a three-dimensional culture system (without LIF) on low cell binding dishes (96-well plate round bottom). This represented day 0 of EB formation. On the next day, the medium was replaced with the same medium without LIF. EBs were re-seeded on gelatin-coated 48-well plates with one EB per well, on day 8 after the start of EB formation. The cardiomyogenic induction was estimated by the beating EB number per total EB number, measured on day 12 under a phase-contrast microscope. Grem1 increased the percentage of beating EBs to 69.2%, as compared with 26.7% in EBs without Grem1 treatment. The numbers in parentheses indicate the EB numbers counted.
###end p 61
###begin p 62
(1.27 MB DOC)
###end p 62
###begin p 63
Click here for additional data file.
###end p 63
###begin p 64
Primer sequences.
###end p 64
###begin p 65
(0.06 MB DOC)
###end p 65
###begin p 66
Click here for additional data file.
###end p 66
###begin p 67
CL6 cells treated with DMSO alone. P19CL6 cells are reproducibly and stably induced into beating cardiomyocytes with DMSO.
###end p 67
###begin p 68
(1.66 MB MOV)
###end p 68
###begin p 69
Click here for additional data file.
###end p 69
###begin p 70
CL6 cells treated with Grem1 (125 ng/ml) and DMSO. Grem1 dramatically promotes DMSO-induced cardiomyogenic differentiation of P19CL6 cells at a concentration of 125 ng/ml.
###end p 70
###begin p 71
(2.40 MB MOV)
###end p 71
###begin p 72
Click here for additional data file.
###end p 72
###begin p 73
###xml 82 85 82 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Id1</italic>
We would like to express our sincere thanks to T. Imamura and K. Miyazono for the Id1 promoter-Lux plasmid, and J. Fujimoto for their discussion of this work.
###end p 73
###begin title 74
References
###end title 74
###begin article-title 75
###xml 100 107 <span type="species:ncbi:9031">chicken</span>
BMP-2 induces ectopic expression of cardiac lineage markers and interferes with somite formation in chicken embryos.
###end article-title 75
###begin article-title 76
A role for bone morphogenetic proteins in the induction of cardiac myogenesis.
###end article-title 76
###begin article-title 77
BMP induction of cardiogenesis in P19 cells requires prior cell-cell interaction(s).
###end article-title 77
###begin article-title 78
Regulation of avian cardiogenesis by Fgf8 signaling.
###end article-title 78
###begin article-title 79
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
The mouse Fgf8 gene encodes a family of polypeptides and is expressed in regions that direct outgrowth and patterning in the developing embryo.
###end article-title 79
###begin article-title 80
###xml 37 46 <span type="species:ncbi:7955">zebrafish</span>
Induction and differentiation of the zebrafish heart requires fibroblast growth factor 8 (fgf8/acerebellar).
###end article-title 80
###begin article-title 81
###xml 34 43 <span type="species:ncbi:7955">zebrafish</span>
fgf20 is essential for initiating zebrafish fin regeneration.
###end article-title 81
###begin article-title 82
The basic helix-loop-helix transcription factor, dHAND, is required for vascular development.
###end article-title 82
###begin article-title 83
Amphibian in vitro heart induction: a simple and reliable model for the study of vertebrate cardiac development.
###end article-title 83
###begin article-title 84
beta-Catenin signaling in biological control and cancer.
###end article-title 84
###begin article-title 85
Development. ES cells to the rescue.
###end article-title 85
###begin article-title 86
Wnt-11 activation of a non-canonical Wnt signalling pathway is required for cardiogenesis.
###end article-title 86
###begin article-title 87
The combinatorial activities of Nkx2.5 and dHAND are essential for cardiac ventricle formation.
###end article-title 87
###begin article-title 88
###xml 55 65 <span type="species:ncbi:7227">Drosophila</span>
The wingless signaling pathway is directly involved in Drosophila heart development.
###end article-title 88
###begin article-title 89
Inhibition of Wnt activity induces heart formation from posterior mesoderm.
###end article-title 89
###begin article-title 90
###xml 42 56 <span type="species:ncbi:8355">Xenopus laevis</span>
Wnt antagonism initiates cardiogenesis in Xenopus laevis.
###end article-title 90
###begin article-title 91
Wnt signals from the neural tube block ectopic cardiogenesis.
###end article-title 91
###begin article-title 92
Development. The path to the heart and the road not taken.
###end article-title 92
###begin article-title 93
Wnt11 facilitates embryonic stem cell differentiation to Nkx2.5-positive cardiomyocytes.
###end article-title 93
###begin article-title 94
A web-based tool for principal component and significance analysis of microarray data.
###end article-title 94
###begin article-title 95
###xml 50 55 <span type="species:ncbi:10090">mouse</span>
Dynamics of global gene expression changes during mouse preimplantation development.
###end article-title 95
###begin article-title 96
http://lgsun.grc.nia.nih.gov/ANOVA/help.html#hierarchical Accessed 2007 April 20. Bioinformatics Advance Access.
###end article-title 96
###begin article-title 97
Phosphatidylinositol 3-kinase-Akt pathway plays a critical role in early cardiomyogenesis by regulating canonical Wnt signaling.
###end article-title 97
###begin article-title 98
The Xenopus dorsalizing factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities.
###end article-title 98
###begin article-title 99
Developmental stage-specific biphasic roles of Wnt/beta-catenin signaling in cardiomyogenesis and hematopoiesis.
###end article-title 99
###begin article-title 100
Wnt and BMP signaling govern lineage segregation of melanocytes in the avian embryo.
###end article-title 100
###begin article-title 101
###xml 37 42 <span type="species:ncbi:9606">human</span>
Sclerostin promotes the apoptosis of human osteoblastic cells: a novel regulation of bone formation.
###end article-title 101
###begin article-title 102
###xml 58 63 <span type="species:ncbi:10090">mouse</span>
Gremlin negatively modulates BMP-4 induction of embryonic mouse lung branching morphogenesis.
###end article-title 102
###begin article-title 103
Antagonists of Wnt and BMP signaling promote the formation of vertebrate head muscle.
###end article-title 103
###begin article-title 104
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse limb deformity mutations disrupt a global control region within the large regulatory landscape required for Gremlin expression.
###end article-title 104
###begin article-title 105
Gremlin-mediated BMP antagonism induces the epithelial-mesenchymal feedback signaling controlling metanephric kidney and limb organogenesis.
###end article-title 105
###begin article-title 106
###xml 89 94 <span type="species:ncbi:10090">mouse</span>
Transient inhibition of BMP signaling by Noggin induces cardiomyocyte differentiation of mouse embryonic stem cells.
###end article-title 106
###begin article-title 107
Persistence of the mitogenic response to platelet-derived growth factor (competence) does not reflect a long-term interaction between the growth factor and the target cell.
###end article-title 107
###begin article-title 108
###xml 51 56 <span type="species:ncbi:9606">human</span>
Regulation of myogenic progenitor proliferation in human fetal skeletal muscle by BMP4 and its antagonist Gremlin.
###end article-title 108
###begin article-title 109
Distinct roles of Wnt/beta-catenin and Bmp signaling during early cardiogenesis.
###end article-title 109
###begin article-title 110
T (Brachyury) is a direct target of Wnt3a during paraxial mesoderm specification.
###end article-title 110
###begin article-title 111
Neural crest stem cell maintenance by combinatorial Wnt and BMP signaling.
###end article-title 111
###begin article-title 112
Hyaline cartilage formation and enchondral ossification modeled with KUM5 and OP9 chondroblasts.
###end article-title 112
###begin p 113
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 113
###begin p 114
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
###xml 582 587 <span type="species:ncbi:9606">Child</span>
Funding: This study was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan and Health and Labor Sciences Research Grants; by a Research grant on Health Science Focusing on Drug Innovation from the Japan Health Science Foundation; by the Program for Promotion of Fundamental Studies in Health Science of the Pharmaceuticals and Medical Devices Agency; by a grant from the Terumo Life Science Foundation; by a Research Grant for Cardiovascular Disease from the Ministry of Health, Labor and Welfare (MHLW); and by a Grant for Child Health and Development from the MHLW.
###end p 114

